戻る Agenda
Scientific Communication Key Message Development, Management, and Dissemination
Session Chair(s)
David B. Clemow, PHD
Advisor, Scientific Communications Information Strategy
Eli Lilly and Company, United States
This session will provide solutions for optimizing key message development and disclosure, including input/output links, data-to-message mapping, and awareness/access details important for strategic alignment of scientific narrative.
Learning Objective : Share scientific key message and narrative development, management, and disclosure processes; Define the cross-functional inputs and outputs of medical/scientific key message development, including the role of advisory board relationships and workshops in message development; Summarize improved and expanded awareness to key messages, including new methods to communicate complex medical information to maximize their value.
Speaker(s)
Scientific Narrative Development: Medical Message Inputs and Disclosure Outputs
David B. Clemow, PHD
Eli Lilly and Company, United States
Advisor, Scientific Communications Information Strategy
The Advisory Board ‘Laboratory’ for Key Message Development
Kristine Jolliffe
Six Degrees Medical Consulting, Canada
Director, Scientific Content
Innovating Medical Communications: Transformative Approaches for Adding Value Through Improved Medical Decision-Making
Wesley Winston Portegies, MBA
Medcomms Experts, United States
Chief Strategy Officer & Founder